This decommissioned ERA site remains active temporarily to support our final migration steps to https://ualberta.scholaris.ca, ERA's new home. All new collections and items, including Spring 2025 theses, are at that site. For assistance, please contact erahelp@ualberta.ca.
Communities and Collections
Usage
- 200 views
- 244 downloads
Elucidating the mechanism by which the antianginal ranolazine mitigates obesity-induced nonalcoholic fatty liver disease
-
- Author(s) / Creator(s)
-
- Date created
- 2019-12-20
-
- Subjects / Keywords
-
- Type of Item
- Conference/Workshop Poster